580
Participants
Start Date
June 27, 2022
Primary Completion Date
May 15, 2026
Study Completion Date
December 30, 2026
Evogliptin
DA-1229 10 mg, 1 tab
Placebo
DA-1229 Placebo, 1 tab
RECRUITING
Ichan School of Medicine, New York
RECRUITING
Stony brook, Stony Brook
RECRUITING
University of Pittsburgh Medical Center, Mechanicsburg
RECRUITING
Einstein Medical Center Philadelphia, Philadelphia
RECRUITING
Inova Health Care Services, Falls Church
RECRUITING
Northside Hospital, Atlanta
RECRUITING
Mayo Clinic, FL, Jacksonville
RECRUITING
Baycare Health systems, Safety Harbor
RECRUITING
OhioHealth Research Institute, Columbus
RECRUITING
Christ Hospital, Cincinnati
RECRUITING
Beaumont Hospital, Royal Oak, Royal Oak
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
Aurora Research Institute, Milwaukee
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Texas Heart Institute, Houston
RECRUITING
University of Colorado, Aurora
RECRUITING
Mayo Clinic, AZ, Phoenix
RECRUITING
University of Southern California, Los Angeles
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Hackensack Meridian Health, Hackensack
RECRUITING
Rutgers- Robert Wood Johnson Medical School, New Brunswick
RECRUITING
The University of Vermont Medical Center, Burlington
NOT_YET_RECRUITING
Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Québec
REDNVIA Co., Ltd.
INDUSTRY